PRODUCTION OF HYPERIMMUNE SERUM AGAINST ANTHRAX
Main Article Content
Authors
B.K. Umuraliyev
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
M.S. Seisenbayeva
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
A.S. Zhakypbek
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
A.S. Rsaliev, JSC National Holding QazBioPharm
JSC National Holding QazBioPharm Astana, Kazakhstan
A.A. Isakhan
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
N.K. Orazymbetova
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
M.ZH. Kaukarbayeva
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
K.D. Zhugunisov
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
Zh.B. Kondibayeva
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
Zh.K Koshemetov
Research Institute for Biological Safety Problems, Gvardeisky, Kazakhstan
E.O. Abduraimov
JSC National Holding QazBioPharm Astana, Kazakhstan
Abstract
This study presents the results of obtaining a specific hyperimmune serum against the causative agent of anthrax (Bacillus anthracis). As antigenic material, purified and inactivated strains “STI-1”, “78/NIIPBB”, and “Anthrax culture (matrix No. 71, Tsienkovsky’s second vaccine)” were used. To accelerate the production of specific antibodies, various hyperimmunization schemes were tested using sheep, goats, and rabbits. Immunization was carried out with adjuvants of different origins — complete Freund’s adjuvant, aluminum hydroxide, and Montanide ISA-70 — at an antigen-to-adjuvant ratio of 1:1. The dynamics of antibody titer increase were evaluated using diffusion precipitation and indirect hemagglutination assays. It was found that the highest antibody titers were observed in goats and rabbits on the 21st day after immunization, reaching 1:2560, indicating a pronounced immune response when combined antigen administration schemes were applied. The results confirm the efficiency of selecting an optimal hyperimmunization strategy and demonstrate the feasibility of using small laboratory and farm animals for producing specific hyperimmune sera against Bacillus anthracis. These findings provide a foundation for developing rapid and cost-effective methods for the production of specific serum preparations.
Keywords
Anthrax, diffusion precipitation reaction, indirect hemagglutination reaction, immunization, serum
Article Details
References
Ivanova S. V., Melnikova L. A., Rodionov A. P., Evstifeev V. V.
Method for obtaining and storing hyperimmune anthrax serum. Veterinariya segodnya (Veterinary Today), 2023, vol. 12, no. 3, pp. 215–221.
Cossaboom C.M., Khaiseb S., Haufiku B., Katjiuanjo P., Kannyinga A., Mbai K. Anthrax epizootic in wildlife, Bwabwata National Park, Namibia, 2017 // Emerging Infectious Diseases. – 2019. – Vol. 25, No. 5. – P. 947–950. DOI: 10.3201/eid2505.180867.
Muturi M., Gachohi J., Mwatondo A., Lekolool I., Gakuya F., Bett A. Recurrent anthrax outbreaks in humans, livestock, and wildlife in the same locality, Kenya, 2014–2017 // American Journal of Tropical Medicine and Hygiene. – 2018. – Vol. 99, No. 4. – P. 833–839. DOI: 10.4269/ajtmh.18-0224.
Mwakapeje E.R., Høgset S., Fyumagwa R., Nonga H.E., Mdegela R.H., Skjerve E. Anthrax outbreaks in the humans–livestock and wildlife interface areas of Northern Tanzania: a retrospective record review 2006–2016 // BMC Public Health. – 2018. – Vol. 18. – P. 106. DOI: 10.1186/s12889-017-5007-z.
Lukhnova L. Yu., Aikimbaev A. M., Ospanov K. S., Temiraliyeva G. A., Pazylov E. K., Gorelov Yu. M. Prevention of anthrax in Kazakhstan. – Almaty: KNCKZI, 2009. – 120 p.
Baigazanov, A.N., Bleim, T.N., Nurkenova, M.K., & Kozlova, S.V. (2021). Epizootological monitoring of anthrax in the Semey region of Kazakhstan. Vestnik Kursk State Agricultural Academy, 1, 45–52.
Zhakypbek, A.S., Seisenbayeva, M.S., Orazymbetova, N.K., Koshemetov, Zh.K., Umuraliev, B.K., & Isakhan, A.A. (2024). Epizootic situation of anthrax in the Republic of Kazakhstan for the period 2014–2023. Bulletin of Osh State University. Agriculture: Agronomy, Veterinary and Zootechny, 2(7), 123–135.
Lukhnova, L.Yu. (Ed.). (2019). Cadastre of settlements stationary unfavorable for anthrax in the Republic of Kazakhstan (1935–2018). Almaty: KNTSKZI.
Galiullin, A.K., & Khisamiev, I.M. (2015). Monitoring of anthrax under modern conditions. Scientific Notes of Kazan State Academy of Veterinary Medicine named after N.E. Bauman, 4, 67–73.
Egorova, I.Yu., & Selyaninov, Yu.O. (2016). Evaluation of efficiency and practical suitability of modern rapid detection methods for anthrax pathogen. Russian Journal of Agricultural and Socio-Economic Sciences (RJOAS), 2(50), 3–13.
Benn J.S., Nunez C.M., Blue-McLendon A., Chaki S.P., Ficht T.A., Rice-Ficht A.C., Cook W.E. Lethal toxin neutralizing antibody response induced following oral vaccination with a microencapsulated Bacillus anthracis Sterne strain 34F2 vaccine proof-of-concept study in white-tailed deer (Odocoileus virginianus) // Journal of Zoo and Wildlife Medicine. – 2024. – Vol. 55, No. 1. – P. 212–218.
Sharma S., Bahl V., Srivastava G., Shamim R., Bhatnagar R., Gaur D. Recombinant full-length Bacillus anthracis protective antigen and its 63 kDa form elicits protective response in formulation with Addavax // Frontiers in Immunology. – 2022. – Vol. 13. – Article 1075662.
Granovskiy D.L., Ryabchevskaya E.M., Evtushenko E.A., Kondakova O.A., Nikitin N.A., Karpova O.V. New formulation of a recombinant anthrax vaccine stabilised with structurally modified plant viruses // Frontiers in Microbiology. – 2022. – Vol. 13. – Article 1003969.
Izbanova U., Rysbekova A., Zhumadilova Z., et al. Epidemiological and molecular analysis of anthrax cases of the Zhambyl region, Kazakhstan in 2023 // Frontiers in Public Health. – 2025. – Vol. 13. – Article 1620930. DOI: 10.3389/fpubh.2025.1620930.
Abutalip A., Suchshikh V., Aitzhanov B., Ospanov Y., Kanatov B. Current state of animal anthrax problems in the Republic of Kazakhstan and ways to solve it // International Journal of Veterinary Science. – 2024. – (Online first). DOI: 10.47278/journal.ijvs/2024.198.
Nizkorodova A.S., Maltseva E.R., Berdygulova Zh.A., Naizabayeva D.A., Skiba Yu.A. Review and analysis of anthrax diagnostic tools on the territory of Eurasian Economic Union // Eurasian Journal of Applied Biotechnology. – 2023. – Т. 3(21). – С. 75–86.
Adone R., Sali M., Francia M., Iatarola M., Donatiello A., Fasanella A. Development of a Sterne-based complement fixation test to monitor the humoral response induced by anthrax vaccines // Frontiers in Microbiology. – 2016. – Vol. 7. – P. 19. DOI: 10.3389/fmicb.2016.00019.
Ndumnego O.C., Koehler S.M., Crafford J.E., Beyer W., van Heerden H. Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model // Scientific Reports. – 2018. – Vol. 8. – P. 16937. DOI: 10.1038/s41598-018-35382-8.
Baillie L., Read T.D. Bacillus anthracis: molecular aspects of virulence and vaccine design // FEMS Microbiology Reviews. – 2020. – Vol. 44, No. 5. – P. 621–639. DOI: 10.1016/s1286-4579(99)80004-5.
Chitlaru T., Altboum Z., Reuveny S., Shafferman A. Progress and novel strategies in the vaccine-based approach against anthrax // Immunological Reviews. – 2016. – Vol. 270, No. 1. – P. 1–16. DOI: 10.1111/j.1600-065X.2010.00969.x.
Mikshis N.I., Popova P.Y., Semakova A.P., Kutyrev V.V. Licensed anthrax vaccines and experimental preparations at the stage of clinical trials // Journal of microbiology, epidemiology and immunobiology. - 2017. - Vol. 94. - N. 4. - P. 112-126. doi: 10.36233/0372-9311-2017-4-112-126.
Pitt M.L.M., Little S.F., Ivins B.E., Fellows P., Boles J., Barth J. In vitro and in vivo correlation of vaccine-induced neutralizing antibody to protection against anthrax challenge in rhesus monkeys // Vaccine. – 2018. – Vol. 36, No. 25. – P. 3640–3647. DOI: 10.1016/s0264-410x(01)00234-1.
Bajzert J., Jawor P., Baran R., Stefaniak T. Subcutaneous application of hyperimmune serum against Histophilus somni recombinant proteins affects serum antibody reactivity in beef calves // BMC Veterinary Research, 2024. DOI: 10.1186/s12917-024-03895-2
Nouri H. R., Razzaz H., Taghdiri M., Tadayyon K., Banihashemi S. R. «Development of Enzyme Linked Immunosorbent Assay for humoral immune response and infection monitoring of anthrax.» // Journal of the Hellenic Veterinary Medical Society. 2020. DOI: 10.12681/jhvms.22964.
Gupta R.K., Rost B.E., Relyveld E.H., Siber G.R. Adjuvants — a balance between toxicity and adjuvanticity // Vaccine. – 1993. – Vol. 11, No. 3. – P. 293–306. DOI: 10.1016/0264-410X(93)90190-9.
Reuveny S., White M.D., Adar Y., Kafri Y., Altboum Z., Gozes Y., Kobiler D. Search for correlates of protective immunity conferred by anthrax vaccine // Infection and Immunity. – 2001. – Vol. 69, No. 5. – P. 2888–2893. DOI: 10.1128/IAI.69.5.2888-2893.2001.
Turnbull PC, Leppla SH, Broster MG, Quinn CP, Melling J. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity // Med Microbiol Immunol. -1988 – Vol.177(5) – P. 293-303. doi: 10.1007/BF00189414. PMID: 3139974.
Selim S.A., El-Sayed A.A., Draz A.A., El-Bagoury G.F., Ibrahim M.H. Development of anthrax hyperimmune serum in small ruminants // Journal of Veterinary Microbiology. – 2011. – Vol. 149, No. 3–4. – P. 421–428. DOI: 10.1016/j.vetmic.2010.10.021.
Carter D, Reed SG. Role of adjuvants in modeling the immune response // Curr Opin HIV AIDS. - 2010 – Vol. 5(5) – P. 409-13. doi: 10.1097/COH.0b013e32833d2cdb.
Wilson J.D., Nakane P.K. Studies on antibody response enhancement by adjuvants // Immunology. – 1978. – Vol. 34, No. 2. – P. 211–219.
Peterson JW, Comer JE, Baze WB, Noffsinger DM, Wenglikowski A, Walberg KG, Hardcastle J, Pawlik J, Bush K, Taormina J, Moen S, Thomas J, Chatuev BM, Sower L, Chopra AK, Stanberry LR, Sawada R, Scholz WW, Sircar J. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model // Infect Immun. - 2007 – Vol.75(7) – P. 3414-24. doi: 10.1128/IAI.00352-07.
Ndumnego O.C., Crafford J., Beyer W., van Heerden H. Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A/J mouse model // Scientific Reports. - 2018. - Vol. 8. - Article 16937. DOI: 10.1038/s41598‑018‑35382‑8.
Ionin B, Hopkins RJ, Pleune B, Sivko GS, Reid FM, Clement KH, Rudge TL Jr, Stark GV, Innes A, Sari S, Guina T, Howard C, Smith J, Swoboda ML, Vert-Wong E, Johnson V, Nabors GS, Skiadopoulos MH. Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis // Clin Vaccine Immunol. 2013 – Vol. 20(7) – P.1016-26. doi: 10.1128/CVI.00099-13.